Global Awareness & Prevention: Strategies & Impact
Okay, hear’s a summary of the provided text, focusing on the key takeaways regarding sexual health news and initiatives:
Key themes & Details:
WHO & Sexual Health measurement: The World Health Association (WHO) is actively working to improve how countries measure and monitor sexual health outcomes, specifically through the advancement of the SHAPE questionnaire. This highlights the importance of sexual health in infectious disease prevention and care.
Aging with HIV: People living with HIV (PLWHIV) are living longer due to antiretroviral therapy (ART), but this brings new health challenges. They are at higher risk for comorbidities like cardiovascular disease, metabolic syndrome, kidney problems, cognitive decline, and frailty. Clinicians need to proactively screen for these issues and provide specialized, multidisciplinary care. New Gonorrhea Treatment Potential: The FDA has granted priority review to gepotidacin, a new oral antibiotic for uncomplicated gonorrhea. Clinical trials showed it to be non-inferior to the current standard treatment (ceftriaxone + azithromycin) and had a good safety profile. Approval would offer a much-needed new treatment option.
New HIV Treatment Regimen Under Review: Merck’s doravirine/islatravir (DOR/ISL),a once-daily two-drug HIV regimen,is under FDA review. Trials suggest it’s effective for maintaining viral suppression in people who switch from existing treatments, with a PDUFA date of April 28, 2026.
In essence, the text showcases progress in both treating existing sexually transmitted infections (STIs) and managing the long-term health of individuals with HIV, alongside a broader effort to improve sexual health monitoring globally.